Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Association of LATE-NC With Neuropathologic Lesions and Cognitive Abilities: A Population-Based Autopsy Study

AI Summary
  • LATE-NC occurred in 7.4% of 1,860 Brazilian autopsies, in an ethnoracially and socioeconomically diverse population-based sample.
  • LATE-NC stages 2 to 3 strongly associated with hippocampal sclerosis (OR 14.95), advanced Braak NFT stages (OR 2.23) and Lewy body pathology (OR 1.89).
  • LATE-NC associated with greater cognitive impairment measured by CDR-SOB (β = 4.06), comparable to moderate to severe ADNC (β = 3.78).
Summarise with AI (MRCPsych/FRANZCP)

Neurology. 2026 Dec 8;107(11):e218694. doi: 10.1212/WNL.0000000000218694. Epub 2026 Nov 5.

ABSTRACT

BACKGROUND AND OBJECTIVES: Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is a common finding in aging brains. However, most previous studies were limited to ethnoracially homogeneous cohorts from high-income countries. The objective of this study was to investigate the associations between LATE-NC, cognitive performance, and coexisting neuropathologic lesions in a large, ethnoracially and socioeconomically diverse sample from Brazil.

METHODS: This cross-sectional study analyzed data from the Biobank for Aging Studies, a Brazilian population-based autopsy study based at the University of São Paulo. The study included a consecutive series of autopsies performed between 2004 and 2024. Inclusion criteria required participants to be at least 18 years old with a knowledgeable informant. LATE-NC, Alzheimer disease neuropathologic change (ADNC), Lewy body pathology (LBP), lacunar infarcts, small vessel disease, cerebral amyloid angiopathy, and hippocampal sclerosis were assessed following international criteria. Cognitive abilities were evaluated with the Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB). Logistic and linear regression models were applied to examine associations of LATE-NC with comorbid neuropathologies and cognitive outcomes, with adjustments for sociodemographic, clinical, and neuropathologic covariates.

RESULTS: The sample comprised 1,860 participants (mean age = 72.6 ± 14.2 years; 49.1% female; 62.2% White; 35.4% Black). LATE-NC was present in 7.4% of participants (stage 1: 3.0%; stage 2: 4.0%; stage 3: 0.4%). After adjustment for sociodemographic, clinical, and other neuropathologic covariates, LATE-NC (stages 2-3) was associated with hippocampal sclerosis (OR = 14.95; 95% CI 7.42-30.27; p < 0.001), advanced Braak NFT stages (OR = 2.23; 95% CI 1.32-3.83; p = 0.003), and LBP (OR = 1.89; 95% CI 1.02-3.37; p = 0.036). Factoring in other pathologies, LATE-NC was associated with the CDR-SOB score (β = 4.06; 95% CI 2.95-5.18; p < 0.001), demonstrating a consistent association with cognition, similar to the one observed for moderate/severe ADNC (β = 3.78; 95% CI 3.14-4.42; p < 0.001) in the same sample.

DISCUSSION: LATE-NC was prevalent and associated with cognitive impairment in this ethnoracially and socioeconomically diverse sample. The cross-sectional design limits causal inference, and some estimates had wide confidence intervals due to the small number of advanced-stage cases.

PMID:42987245 | DOI:10.1212/WNL.0000000000218694

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD